Clinical Cancer Research, Vol 3, Issue 10 1849-1857, Copyright © 1997 by American Association for Cancer Research

ARTICLES

Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma

M Engelhardt, J Albanell, P Drullinsky, W Han, J Guillem, HI Scher, V Reuter and MA Moore
James Ewing Laboratory of Developmental Hematopoiesis, Genitourinary Oncology Service, Departments of Surgery and Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

Telomerase and telomere length are increasingly investigated as potential diagnostic and prognostic markers in human tumors. Among other factors, telomerase and telomere length may be influenced by the degree of tumor cell content in tumor specimens. We studied telomerase activity and telomere length with concomitant integration of histopathological data to determine whether both were influenced by the amount of tumor cells. We measured telomerase in 153 specimens: in 51 solid tumor blocks; in 51 cryostat sections; and in 51 adjacent normal tissues from patients with sarcoma (n = 10) and colorectal (n = 11) and prostate cancer (n = 30) using the sensitive and rapid detection telomeric repeat amplification protocol assay. Telomere length was determined by telomere restriction fragment Southern blot analysis. From cryostat sections, tumor cell infiltration was assessed. Telomerase activity was detected in all colorectal tumors and sarcomas, as expected. In primary prostate cancer, however, telomerase activity was less frequently observed (14 of 30, 47%). Moreover, a decreased intensity compared to colon cancer and sarcoma was evident (P < 0.001). The median tumor cell infiltration was significantly higher in sarcoma (65%) and colon (30%) compared to prostate cancer (5%; P < 0.001). There was a positive correlation between tumor cell infiltration and telomerase activity (r = 0.89; P < 0.001). Telomere restriction fragments in tumors were shorter compared to the normal tissues with peak differences in colon, sarcoma, and prostate of 1.8, 2.8, and 1 kilobase pairs, respectively (P < 0.002). Our data suggest the presence of a positive correlation between the degree of tumor cell content in human solid tumors and the level of telomerase activity detected. We demonstrated that the amount of tumor cells also affects telomere restriction fragment analysis. Therefore, with the predominance of normal cells in tumor specimens, telomerase activity measured may not reflect the malignant phenotype, and telomere loss may be underestimated. This phenomenon was most evident in prostate cancer. Our results will have implications for the future when telomerase activity and telomere lengths may be used for early screening, diagnosis, and prognosis determinations and when telomerase inhibitors are applied to clinical practice.

This article has been cited by other articles:

				S. H. Ghaffari, N. Shayan-Asl, A. H. Jamialahmadi, K. Alimoghaddam, and A. Ghavamzadeh Telomerase activity and telomere length in patients with acute promyelocytic leukemia: indicative of proliferative activity, disease progression, and overall survival Ann. Onc., June 20, 2008; (2008) mdn394v1. [Abstract] [Full Text] [PDF]

				P.-H. Wang, G.-D. Chen, H. Chang, S.-F. Yang, C.-P. Han, L.-Y. Lin, and J.-L. Ko High Expression of Human Telomerase Reverse Transcriptase in High-Grade Intraepithelial Neoplasia and Carcinoma of Uterine Cervix and Its Correlation With Human Papillomavirus Infection Reproductive Sciences, May 1, 2007; 14(4): 338 - 348. [Abstract] [PDF]

				B. M. Unryn, D. Hao, S. Gluck, and K. T. Riabowol Acceleration of telomere loss by chemotherapy is greater in older patients with locally advanced head and neck cancer. Clin. Cancer Res., November 1, 2006; 12(21): 6345 - 6350. [Abstract] [Full Text] [PDF]

				E. Montgomery, P. Argani, J. L. Hicks, A. M. DeMarzo, and A. K. Meeker Telomere Lengths of Translocation-Associated and Nontranslocation-Associated Sarcomas Differ Dramatically Am. J. Pathol., May 1, 2004; 164(5): 1523 - 1529. [Abstract] [Full Text] [PDF]

				R. N. Damle, F. M. Batliwalla, F. Ghiotto, A. Valetto, E. Albesiano, C. Sison, S. L. Allen, J. Kolitz, V. P. Vinciguerra, P. Kudalkar, et al. Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations Blood, January 15, 2004; 103(2): 375 - 382. [Abstract] [Full Text] [PDF]

				R R Plentz, S U Wiemann, P Flemming, P N Meier, S Kubicka, H Kreipe, M P Manns, and K L Rudolph Telomere shortening of epithelial cells characterises the adenoma-carcinoma transition of human colorectal cancer Gut, September 1, 2003; 52(9): 1304 - 1307. [Abstract] [Full Text]

				K.-D. Wu, L. M. Orme, J. Shaughnessy Jr, J. Jacobson, B. Barlogie, and M. A. S. Moore Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival Blood, June 15, 2003; 101(12): 4982 - 4989. [Abstract] [Full Text] [PDF]

				A. K. Meeker, J. L. Hicks, E. A. Platz, G. E. March, C. J. Bennett, M. J. Delannoy, and A. M. De Marzo Telomere Shortening Is an Early Somatic DNA Alteration in Human Prostate Tumorigenesis Cancer Res., November 15, 2002; 62(22): 6405 - 6409. [Abstract] [Full Text] [PDF]

				A. K. Meeker, W. R. Gage, J. L. Hicks, I. Simon, J. R. Coffman, E. A. Platz, G. E. March, and A. M. De Marzo Telomere Length Assessment in Human Archival Tissues : Combined Telomere Fluorescence in Situ Hybridization and Immunostaining Am. J. Pathol., April 1, 2002; 160(4): 1259 - 1268. [Abstract] [Full Text] [PDF]

				M. Engelhardt, K. Mackenzie, P. Drullinsky, R. T. Silver, and M. A. S. Moore Telomerase Activity and Telomere Length in Acute and Chronic Leukemia, Pre- and Post-ex Vivo Culture Cancer Res., February 1, 2000; 60(3): 610 - 617. [Abstract] [Full Text]

				J. Albanell, G. J. Bosl, V. E. Reuter, M. Engelhardt, S. Franco, M. A. S. Moore, and E. Dmitrovsky Telomerase Activity in Germ Cell Cancers and Mature Teratomas J Natl Cancer Inst, August 4, 1999; 91(15): 1321 - 1326. [Abstract] [Full Text] [PDF]